2021 Summit Virtual Lobby Day Recap After four days of summit programming and lobby day prep, on Tuesday, May 18, […]
“Changes to FDA warnings and labeling should be grounded in rigorous, contemporary evidence—not post-hoc or subgroup re-analyses of older trials. ”
“As a breast cancer survivor, [Visco] turned pain into purpose, changed the landscape of breast cancer advocacy, and has become a powerful symbol of hope for the nation.”
Nicole Levins, communications director
nlevins@stopbreastcancer.org
2021 Summit Virtual Lobby Day Recap After four days of summit programming and lobby day prep, on Tuesday, May 18, […]
ODAC Votes. Win for Industry, Not for Patients. On April 27, 2021, at the Oncologic Drug Advisory Committee (ODAC) […]
We all want new treatments to “work” for breast cancer patients. For the National Breast Cancer Coalition (NBCC), that means […]
WASHINGTON, DC – The National Breast Cancer Coalition is proud to announce bipartisan support for a bill to waive onerous […]
NBCC Statement on the Passing of Congressman Alcee Hastings We have lost another leader in our mission to end breast […]
